論文・総説 - 新井　文子

分割表示  117 件中 61 - 80 件目  ／  全件表示 >>

  1. Ayako Arai, Mae Aoki, Yan Weihua, Aishun Jin, Osamu Miura. CrkL plays a role in SDF-1-induced activation of the Raf-1/MEK/Erk pathway through Ras and Rac to mediate chemotactic signaling in hematopoietic cells. Cell. Signal.. 2006.12; 18 (12): 2162-2171. ( PubMed, DOI )

  2. A Jin, T Kurosu, K Tsuji, D Mizuchi, A Arai, H Fujita, M Hattori, N Minato, O Miura. BCR/ABL and IL-3 activate Rap1 to stimulate the B-Raf/MEK/Erk and Akt signaling pathways and to regulate proliferation, apoptosis, and adhesion. Oncogene. 2006.07; 25 (31): 4332-4340. ( PubMed, DOI )

  3. Ken-Ichi Imadome, Norio Shimizu, Ayako Arai, Osamu Miura, Ken Watanabe, Hiroyuki Nakamura, Shigeaki Nonoyama, Kohtaro Yamamoto, Shigeyoshi Fujiwara. Coexpression of CD40 and CD40 ligand in Epstein-Barr virus-infected T and NK cells and their role in cell survival. J. Infect. Dis.. 2005.10; 192 (8): 1340-1348. ( PubMed, DOI )

  4. Ayako Arai, Asako Kitano, Tetsuya Kurosu, Koh Yamamoto, Tohru Miki, Naomi Murakami, Osamu Miura. Fluid retention during arsenic trioxide treatment in acute promyelocytic leukemia. Am. J. Hematol.. 2005.07; 79 (3): 247-248. ( PubMed, DOI )

  5. Ayako Arai, Aishun Jin, Weihua Yan, Daisuke Mizuchi, Koh Yamamoto, Toshihiro Nanki, Osamu Miura. SDF-1 synergistically enhances IL-3-induced activation of the Raf-1/MEK/Erk signaling pathway through activation of Rac and its effector Pak kinases to promote hematopoiesis and chemotaxis. Cell. Signal.. 2005.04; 17 (4): 497-506. ( PubMed, DOI )

  6. Zhen-Hua Jin, Tetsuya Kurosu, Mitsuko Yamaguchi, Ayako Arai, Osamu Miura. Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis. Oncogene. 2005.03; 24 (12): 1973-1981. ( PubMed, DOI )

  7. Daisuke Mizuchi, Tetsuya Kurosu, Aiko Kida, Zhen-Hua Jin, Aishun Jin, Ayako Arai, Osamu Miura. BCR/ABL activates Rap1 and B-Raf to stimulate the MEK/Erk signaling pathway in hematopoietic cells. Biochem. Biophys. Res. Commun.. 2005.01; 326 (3): 645-651. ( PubMed, DOI )

  8. Eiichiro Kanda, Zhen-Hua Jin, Daisuke Mizuchi, Ayako Arai, Osamu Miura. Activation of Rac and tyrosine phosphorylation of cytokine receptors induced by cross-linking of integrin alpha4beta1 and cell adhesion in hematopoietic cells. Biochem. Biophys. Res. Commun.. 2003.02; 301 (4): 934-940. ( PubMed )

  9. Ayako Arai, Eiichiro Kanda, Osamu Miura. Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway. Oncogene. 2002.04; 21 (17): 2641-2651. ( PubMed, DOI )

  10. A Arai, E Kanda, Y Nosaka, N Miyasaka, O Miura. CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling. J. Biol. Chem.. 2001.08; 276 (35): 33282-33290. ( PubMed, DOI )

  11. Y Nosaka, A Arai, E Kanda, T Akasaki, H Sumimoto, N Miyasaka, O Miura. Rac is activated by tumor necrosis factor alpha and is involved in activation of Erk. Biochem. Biophys. Res. Commun.. 2001.07; 285 (3): 675-679. ( PubMed, DOI )

  12. A Arai, Y Nosaka, E Kanda, K Yamamoto, N Miyasaka, O Miura. Rap1 is activated by erythropoietin or interleukin-3 and is involved in regulation of beta1 integrin-mediated hematopoietic cell adhesion. J. Biol. Chem.. 2001.03; 276 (13): 10453-10462. ( PubMed, DOI )

  13. Y Nosaka, A Arai, N Miyasaka, O Miura. CrkL mediates Ras-dependent activation of the Raf/ERK pathway through the guanine nucleotide exchange factor C3G in hematopoietic cells stimulated with erythropoietin or interleukin-3. J. Biol. Chem.. 1999.10; 274 (42): 30154-30162. ( PubMed )

  14. A Arai, Y Nosaka, H Kohsaka, N Miyasaka, O Miura. CrkL activates integrin-mediated hematopoietic cell adhesion through the guanine nucleotide exchange factor C3G. Blood. 1999.06; 93 (11): 3713-3722. ( PubMed )

  15. H Chin, A Arai, H Wakao, R Kamiyama, N Miyasaka, O Miura. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway. Blood. 1998.05; 91 (10): 3734-3745. ( PubMed )

  16. K Yamamoto, H Kobayashi, A Arai, O Miura, S Hirosawa, N Miyasaka. cDNA cloning, expression and chromosome mapping of the human STAT4 gene: both STAT4 and STAT1 genes are mapped to 2q32.2-->q32.3. Cytogenet. Cell Genet.. 1997.12; 77 (3-4): 207-210. ( PubMed )

  17. H Chin, T Saito, A Arai, K Yamamoto, R Kamiyama, N Miyasaka, O Miura. Erythropoietin and IL-3 induce tyrosine phosphorylation of CrkL and its association with Shc, SHP-2, and Cbl in hematopoietic cells. Biochem. Biophys. Res. Commun.. 1997.10; 239 (2): 412-417. ( PubMed, DOI )

  18. T Miki, N Kawamata, A Arai, K Ohashi, Y Nakamura, A Kato, S Hirosawa, N Aoki. Molecular cloning of the breakpoint for 3q27 translocation in B-cell lymphomas and leukemias. Blood. 1994.01; 83 (1): 217-222. ( PubMed )

  19. 新井文子、細井広子、氏家一知、桃井優、松田正樹、末永松彦、田中耕、星野正信. 維持透析中に肝膿瘍を合併した１例 日本透析療法学会雑誌. 1993.05; 26 (5): 685-688.

  20. 新井　文子. 慢性活動性Epstein-Barrウイルス感染症の克服を目指して 臨床血液. 2021.07; 62 (7): 835-845. ( PubMed, DOI )

< 前のページ - 次のページ >

このページの先頭へ▲